The House Energy and Commerce health panel will hold a hearing on antibiotic resistance and drug development Friday (Sept. 19) as part of the committee's medical innovation initiative that committee Chair Fred Upton (R-MI) said will culminate in legislation synthesizing findings from the effort by January of 2015. Last year Reps. Phil Gingrey (R-GA) and Gene Green (D-TX) introduced the Antibiotic Development to Advance Patient Treatment (ADAPT) Act that would establish a limited population approval pathway for antibiotics -- a...